Hikma reiterates full year guidance following good start to the year
Amman, Jordan: Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading ahead of its Annual General Meeting.
Riad Mishlawi, Hikma's CEO, said:
'We are pleased to reiterate our Group guidance for 2025. As a global company with strong local expertise and footprint, we are leveraging our manufacturing proficiency and advanced technologies to meet the needs of our customers and patients across our markets. Looking ahead, and recognising the broader geo-political challenges, we are well-positioned. Our step up in R&D investment, alongside local manufacturing enhancements, and strategic partnerships will continue to strengthen our portfolio and pipeline and ensure sustained success."
Injectables
Our global Injectables business is delivering a solid revenue performance, driven by each of our three geographies. We are seeing strong demand for our products across our European and MENA markets, where we continue to launch new products. In North America we are benefitting from good demand for the recently launched liraglutide injection and the contribution from the newly acquired Xellia portfolio. This is helping to offset increased competition across some of our existing higher margin products.
We expect momentum to improve in the second half driven by new product launches and contract manufacturing. We are making excellent progress in the enhancements to our Bedford, Ohio facility, which will significantly increase our US-based injectables manufacturing capacity.
We continue to expect 2025 Injectables revenue to grow in the range of 7% to 9%. Phasing and mix of sales will impact margins in the first half but we continue to expect full year core operating margin to be in the mid-30s.
Branded
Our Branded business is performing well. We continue to make good progress in building our diversified portfolio of products used to treat chronic illnesses, with a focus on oncology and lifestyle diseases, supported by our global expertise and strong local market position.
Our leading presence in the MENA region, combined with the breadth of our reach and strong commercial capabilities positions us as a partner of choice. We recently signed an exclusive licensing agreement with pharmaand GmbH, a global pharmaceutical business based in Vienna, to commercialise rucaparib, an innovative small-molecule oral oncology therapy, across the MENA region. This is in line with our strategy to be a leading provider of oncology medicines in the region.
We continue to expect 2025 Branded revenue to grow in the range of 6% to 7% in constant currency, with core EBIT margin close to 25%.
Generics
In our Generics business we are seeing solid demand across our differentiated portfolio, particularly for our nasal and inhalation products. By focusing on reliability of supply, high service levels and leveraging our US manufacturing facility, we are successfully securing longer-term customer awards.
We continue to strengthen our R&D capabilities, including building a team in our new Zagreb, Croatia R&D centre, and are progressing with key development projects that will help strengthen our portfolio and pipeline for the medium to long-term. We are progressing well preparing our Columbus facility to accommodate our recently announced contract manufacturing partnership, and we are seeing increasing demand for our high-quality US-based manufacturing services.
We continue to expect Generics revenue to be broadly flat in 2025 with core operating margin of around 16%.
International trade policies
We are confident that our significant and expanding US manufacturing footprint, which supplies the majority of our US sales, combined with our focus on quality and reliability of supply, positions us well and underpins our resilience in the current environment. We do import some finished products into the US as well as capital equipment, and we have a diversified global supply chain for our raw and packaging materials, including active pharmaceutical ingredients (API).
Full year outlook unchanged
We continue to expect Group revenue to grow in the range of 4% to 6% and for core operating profit to be in the range of $730 million to $770 million in 2025. Group core operating profit growth, which is around 4% at the midpoint of guidance, will be weighted to the second half. We are monitoring the evolving tariff backdrop and will look to remain agile in responding to both opportunities and impacts where possible, but have not reflected an impact from tariffs in our full year outlook.
About Hikma
Hikma helps put better health within reach every day for millions of people around the world. For more than 45 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across North America, the MENA and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 9,500 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com
*Source: AETOSWire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
24 minutes ago
- Al Etihad
Beijing proposes leasing export of rare earths to EU
7 June 2025 14:35 Beijing (AFP)China has proposed establishing a 'green channel' to ease the export of rare earths to the European Union, the commerce ministry said Saturday, after Beijing restricted their sale has since April required licenses to export these strategic materials from China, which accounts for more than 60 percent of rare earth mining production and 92 percent of global refined output, according to the International Energy metals are used in a wide variety of products, including electric car batteries, and there has been criticism from industries about the way China's licenses have been issued.'Export control on rare earths and other items is an international practice,' the commerce ministry said in a statement.'China attaches great importance to Europe's concerns and is willing to establish a green channel for eligible applications, fast track the examination and approval, and instruct the working level to maintain timely communication on this,' a ministry statement comments were attributed to China's Commerce Minister Wang Wentao, who met Tuesday with EU trade commissioner Maros the bilateral talks, Wang said he hoped the bloc would turn 'take reciprocal action, adopt effective measures to facilitate, safeguard, and promote compliant trade of high-tech products with China,' according to the commerce two officials also discussed imports by European countries of Chinese electric vehicles, which the EU has hit with levies over allegedly unfair subsidies from Beijing.'The negotiation on the price commitment of electric vehicles between China and Europe has entered the final stage, but both sides still need to make efforts,' the commerce ministry said. The discussions will be followed by China hosting a summit with the EU next month, 50 years since Beijing and Brussels established diplomatic relations.
Gulf Today
an hour ago
- Gulf Today
The rate is in a safe neutral position
The European Central Bank has reduced the interest rate to 2 per cent from 2.25 per cent, and it seems to have completed the cycle of reduction of rates from 4.25 per cent in June 2024. Markets are betting that the central bank would not reduce any further when it meets in July. The rate is now in a neutral position, where it can neither stimulate growth nor serve as a restraint. Bank president Christine Lagarde said at a press conference, 'At the current level we believe we are in a good position to navigate the uncertain circumstances that will be coming up.' She also said that the bank does not have any pre-determined position on the rate path, and it will take things as they turn out. The two major challenges that the European Union (EU) faces is the slow growth in the economy on the continent, and the tariffs that US President Donald Trump had announced on European imports as he did on imports from all American trade partners. European leaders are looking to negotiations but they have taken a firm position that they will not capitulate to the tariff threats of Washington. Because of lower economic growth, inflation is also aligned to the interest rate. There is however no clear monetary strategy to handle the present state of the European economy. The obvious way forward is to lower interest still further – and there is room for that between the existing 2 per cent and zero interest rate – to revive domestic investment demand. The problem that the European economy is facing is the pressure on its exports, which is a major anchor for European economic growth. In the May World Economic Outlook (WEO), the International Monetary Fund (IMF) says that the euro area will grow by 0.8 per cent in 2025 and by 1.2 per cent in 2026. There is 0.2 per cent reduction in the growth projection for the two years since the January 2025 WEO. Though the Central, Eastern and South-Eastern Europe (CESEE) seems to be doing slightly better than the advanced European economies, the projected figures show a slowing down of growth. For CESEE, it shows a growth of 2.4 per cent for 2025, a reduction by 0.6 per cent, and 2.7 per cent in 2026, a reduction by 0.4 per cent from the January projections. Europe's economic woes precede Trump's tariff onslaught. And the reasons are many. One of the major issues is the demography. The ageing population impacts the workforce, and the governments are burdened with social security commitments. It is surprising that the anti-immigrant right-wing parties have been making political headway in the elections across the continent. What Europe needs is an immigration policy to reinforce its workforce, and the skilling of the immigrants to take their place in the factories. But the governments do not have a policy of integrating the immigrants into the workforce. The second major issue is the burden of climate change and the energy transition that many of the EU members are committed to make. The plain fact is that Europe cannot hope to continue with the old fossil fuel-based production processes. The climate change processes involve financial commitments and the results will be slow in showing in terms of cleaning up the air, the rivers, and the reduction of greenhouse gas emissions. And more importantly, the global markets are changing, and the slowdown of exports will affect the European economy more than ever. The challenges that Europe faces are formidable. And the political responses have been quite erratic. The rise of right-wing political parties with their outdated notions that there is no climate change and that immigrants pose a problem to the prosperity of Europe is not really helpful.
Arabian Post
2 hours ago
- Arabian Post
Debswana Scales Back Diamond Output Amid Global Market Slump
Debswana Diamond Company, Botswana's premier diamond producer, has initiated a significant reduction in its mining operations, citing sustained global demand weakness and mounting economic pressures. The company, a 50-50 joint venture between the Botswana government and De Beers, announced a temporary halt in production at key sites, including the Jwaneng Cut-9 and Orapa mines, aligning output with the subdued market conditions. This strategic move follows a challenging fiscal year for Debswana, which experienced a 46% decline in sales revenue in 2024 compared to the previous year. Production volumes also saw a downturn, with output dropping by 27% to 17.93 million carats. Looking ahead, the company has set a reduced production target of 15 million carats for 2025, marking a 16% decrease from the previous year's figures. The global diamond industry has been grappling with a confluence of adverse factors since mid-2023. Persistent low demand across the diamond pipeline, exacerbated by US-imposed tariffs, has created additional market pressures. An oversupply of certain diamond categories, particularly smaller and lower-quality stones, coupled with shifting consumer preferences towards lab-grown alternatives, has further disrupted traditional demand dynamics. Economic uncertainties in key markets, including inflationary pressures and changing luxury spending patterns, have compounded these challenges. ADVERTISEMENT In response to these market conditions, Debswana has implemented cost-saving measures, including the suspension of operations at the Letlhakane tailings and Jwaneng Modular plants. The company has emphasized its commitment to avoiding involuntary job cuts, offering voluntary separation packages to employees as part of its cost-control strategy. The downturn in the diamond market has had significant repercussions for Botswana's economy, which is heavily reliant on diamond revenues. Diamonds account for approximately 30% of the nation's revenue and 75% of its foreign exchange earnings. The economic contraction in 2024 was recorded at 3%, with the International Monetary Fund projecting a further 0.4% decline in 2025. The government has revised its 2025 economic growth forecast to near zero, a stark contrast to the 3.3% growth anticipated in its February budget presentation. Debswana's decision to scale back production is part of a broader effort to stabilize the market and manage operational costs. While some capital projects have been slowed down, long-term initiatives like the Jwaneng underground conversion will continue. The company aims to achieve significant cost savings across areas such as fuel and electricity consumption during this period of reduced activity. As Botswana navigates these economic challenges, the government continues to explore avenues for economic diversification. Efforts to boost sectors such as tourism, finance, and the mining of other minerals like copper are ongoing. However, the country's heavy dependence on diamond sales underscores the urgency of these diversification initiatives to mitigate the impact of future market downturns.
